{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T12:07:32Z","timestamp":1793707652663,"version":"4.6.1"},"reference-count":167,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,2,19]],"date-time":"2019-02-19T00:00:00Z","timestamp":1550534400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"name":"Hillman Cancer Center and Magee Women's Research Institute","award":["K08 CA211362"],"award-info":[{"award-number":["K08 CA211362"]}]},{"DOI":"10.13039\/100000009","name":"NIH","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000009","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000009","name":"NIH","doi-asserted-by":"publisher","award":["R01 CA211913"],"award-info":[{"award-number":["R01 CA211913"]}],"id":[{"id":"10.13039\/100000009","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","translationalres.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Translational Research"],"published-print":{"date-parts":[[2019,7]]},"DOI":"10.1016\/j.trsl.2019.02.006","type":"journal-article","created":{"date-parts":[[2019,2,23]],"date-time":"2019-02-23T12:33:16Z","timestamp":1550925196000},"page":"55-67","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":231,"special_numbering":"C","title":["The double edge sword of fibrosis in cancer"],"prefix":"10.1016","volume":"209","author":[{"given":"Chelsea","family":"Chandler","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianshi","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronald","family":"Buckanovich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3753-1652","authenticated-orcid":false,"given":"Lan G.","family":"Coffman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.trsl.2019.02.006_bib0001","doi-asserted-by":"crossref","first-page":"33","DOI":"10.3389\/fcell.2015.00033","article-title":"A top-down view of the tumor microenvironment: structure, cells and signaling","volume":"3","author":"Bhome","year":"2015","journal-title":"Front Cell Dev Biol"},{"key":"10.1016\/j.trsl.2019.02.006_bib0002","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1158\/1078-0432.CCR-08-0149","article-title":"Targeting inflammatory pathways for prevention and therapy of cancer: short-term friend, long-term foe","volume":"15","author":"Aggarwal","year":"2009","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.trsl.2019.02.006_bib0003","doi-asserted-by":"crossref","first-page":"12877","DOI":"10.1073\/pnas.162488599","article-title":"Diversity, topographic differentiation, and positional memory in human fibroblasts","volume":"99","author":"Chang","year":"2002","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.trsl.2019.02.006_bib0004","first-page":"G809","article-title":"Intestinal fibroblasts regulate intestinal epithelial cell proliferation via hepatocyte growth factor","volume":"274","author":"G\u00f6ke","year":"1998","journal-title":"Am J Physiol"},{"key":"10.1016\/j.trsl.2019.02.006_bib0005","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1097\/01.PRS.0000069710.48139.4E","article-title":"Effects of subepithelial fibroblasts on epithelial differentiation in human skin and oral mucosa: heterotypically recombined organotypic culture model","volume":"112","author":"Okazaki","year":"2003","journal-title":"Plast Reconstr Surg"},{"key":"10.1016\/j.trsl.2019.02.006_bib0006","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.it.2004.11.014","article-title":"A stromal address code defined by fibroblasts","volume":"26","author":"Parsonage","year":"2005","journal-title":"Trends Immunol"},{"key":"10.1016\/j.trsl.2019.02.006_bib0007","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.4161\/cbt.5.12.3354","article-title":"Identification of fibroblast heterogeneity in the tumor microenvironment","volume":"5","author":"Sugimoto","year":"2006","journal-title":"Cancer Biol Ther"},{"key":"10.1016\/j.trsl.2019.02.006_bib0008","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.ydbio.2017.03.020","article-title":"Temporal, spatial, and phenotypical changes of PDGFR\u03b1 expressing fibroblasts during late lung development","volume":"425","author":"Endale","year":"2017","journal-title":"Dev Biol"},{"key":"10.1016\/j.trsl.2019.02.006_bib0009","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1513\/pats.200708-146DR","article-title":"Biology of fibroblasts and myofibroblasts","volume":"5","author":"Phan","year":"2008","journal-title":"Proc Am Thorac Soc"},{"key":"10.1016\/j.trsl.2019.02.006_bib0010","doi-asserted-by":"crossref","first-page":"10204","DOI":"10.1038\/ncomms10204","article-title":"Epigenetic switch drives the conversion of fibroblasts into proinvasive cancer-associated fibroblasts","volume":"6","author":"Albrengues","year":"2015","journal-title":"Nat Commun"},{"key":"10.1016\/j.trsl.2019.02.006_bib0011","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1002\/ijc.28035","article-title":"Novel signatures of cancer-associated fibroblasts","volume":"133","author":"Boz\u00f3ky","year":"2013","journal-title":"Int J Cancer"},{"key":"10.1016\/j.trsl.2019.02.006_bib0012","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1038\/nrc1877","article-title":"Fibroblasts in cancer","volume":"6","author":"Kalluri","year":"2006","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.trsl.2019.02.006_bib0013","doi-asserted-by":"crossref","DOI":"10.1242\/dmm.029447","article-title":"A peek into cancer-associated fibroblasts: origins, functions and translational impact","volume":"11","author":"LeBleu","year":"2018","journal-title":"Dis Model Mech"},{"key":"10.1016\/j.trsl.2019.02.006_bib0014","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1038\/nrc.2016.73","article-title":"The biology and function of fibroblasts in cancer","volume":"16","author":"Kalluri","year":"2016","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.trsl.2019.02.006_bib0015","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1182\/blood-2012-08-449413","article-title":"Fibrocytes represent a novel MDSC subset circulating in patients with metastatic cancer","volume":"122","author":"Zhang","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.trsl.2019.02.006_bib0016","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1038\/nri2990","article-title":"Fibrocytes: emerging effector cells in chronic inflammation","volume":"11","author":"Reilkoff","year":"2011","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.trsl.2019.02.006_bib0017","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1002\/stem.1648","article-title":"Tracking the elusive fibrocyte: identification and characterization of collagen-producing hematopoietic lineage cells during murine wound healing","volume":"32","author":"Suga","year":"2014","journal-title":"Stem Cells"},{"key":"10.1016\/j.trsl.2019.02.006_bib0018","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1164\/rccm.200810-1534OC","article-title":"Circulating fibrocytes are an indicator of poor prognosis in idiopathic pulmonary fibrosis","volume":"179","author":"Moeller","year":"2009","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.trsl.2019.02.006_bib0019","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/j.neo.2015.04.004","article-title":"Hematopoietic stem cell-derived cancer-associated fibroblasts are novel contributors to the pro-tumorigenic microenvironment","volume":"17","author":"McDonald","year":"2015","journal-title":"Neoplasia"},{"key":"10.1016\/j.trsl.2019.02.006_bib0020","doi-asserted-by":"crossref","first-page":"3340","DOI":"10.1172\/JCI43230","article-title":"CTGF directs fibroblast differentiation from human mesenchymal stem\/stromal cells and defines connective tissue healing in a rodent injury model","volume":"120","author":"Lee","year":"2010","journal-title":"J Clin Invest"},{"key":"10.1016\/j.trsl.2019.02.006_bib0021","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.ccr.2011.01.020","article-title":"Bone marrow-derived myofibroblasts contribute to the mesenchymal stem cell niche and promote tumor growth","volume":"19","author":"Quante","year":"2011","journal-title":"Cancer Cell"},{"key":"10.1016\/j.trsl.2019.02.006_bib0022","doi-asserted-by":"crossref","first-page":"e4992","DOI":"10.1371\/journal.pone.0004992","article-title":"Mesenchymal stem cell transition to tumor-associated fibroblasts contributes to fibrovascular network expansion and tumor progression","volume":"4","author":"Spaeth","year":"2009","journal-title":"PLoS One"},{"key":"10.1016\/j.trsl.2019.02.006_bib0023","series-title":"Stem cell aging: mechanisms, consequences, rejuvenation","first-page":"287","article-title":"Mesenchymal stem cells in wound repair, tissue homeostasis, and aging","author":"Jiang","year":"2015"},{"key":"10.1016\/j.trsl.2019.02.006_bib0024","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1080\/14653240600855905","article-title":"Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement","volume":"8","author":"Dominici","year":"2006","journal-title":"Cytotherapy"},{"key":"10.1016\/j.trsl.2019.02.006_bib0025","doi-asserted-by":"crossref","first-page":"2204","DOI":"10.1242\/jcs.02932","article-title":"Mesenchymal stem cells reside in virtually all post-natal organs and tissues","volume":"119","author":"da Silva Meirelles","year":"2006","journal-title":"J Cell Sci"},{"key":"10.1016\/j.trsl.2019.02.006_bib0026","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1038\/ncomms2766","article-title":"Recruitment of mesenchymal stem cells into prostate tumours promotes metastasis","volume":"4","author":"Jung","year":"2013","journal-title":"Nat Commun"},{"key":"10.1016\/j.trsl.2019.02.006_bib0027","doi-asserted-by":"crossref","first-page":"1939","DOI":"10.1111\/cas.13334","article-title":"Double-edged sword of mesenchymal stem cells: Cancer-promoting versus therapeutic potential","volume":"108","author":"Lee","year":"2017","journal-title":"Cancer Sci"},{"key":"10.1016\/j.trsl.2019.02.006_bib0028","doi-asserted-by":"crossref","first-page":"e10088","DOI":"10.1371\/journal.pone.0010088","article-title":"A new mesenchymal stem cell (MSC) paradigm: polarization into a pro-inflammatory MSC1 or an Immunosuppressive MSC2 phenotype","volume":"5","author":"Waterman","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.trsl.2019.02.006_bib0029","doi-asserted-by":"crossref","first-page":"3206","DOI":"10.1172\/JCI45273","article-title":"Human ovarian carcinoma\u2013associated mesenchymal stem cells regulate cancer stem cells and tumorigenesis via altered BMP production","volume":"121","author":"McLean","year":"2011","journal-title":"J Clin Invest"},{"key":"10.1016\/j.trsl.2019.02.006_bib0030","doi-asserted-by":"crossref","first-page":"6916","DOI":"10.18632\/oncotarget.6870","article-title":"Human carcinoma-associated mesenchymal stem cells promote ovarian cancer chemotherapy resistance via a BMP4\/HH signaling loop","volume":"7","author":"Coffman","year":"2016","journal-title":"Oncotarget"},{"issue":"suppl 1","key":"10.1016\/j.trsl.2019.02.006_bib0031","doi-asserted-by":"crossref","first-page":"S6","DOI":"10.1186\/2047-783X-19-S1-S6","article-title":"Stellate cells are mesenchymal stem cells","volume":"19","author":"Kordes","year":"2014","journal-title":"Eur J Med Res"},{"key":"10.1016\/j.trsl.2019.02.006_bib0032","series-title":"Pancreatic cancer and tumor microenvironment","article-title":"Pancreatic stellate cells and fibrosis","author":"Phillips","year":"2012"},{"key":"10.1016\/j.trsl.2019.02.006_bib0033","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/j.bbrc.2006.11.029","article-title":"CD133+ hepatic stellate cells are progenitor cells","volume":"352","author":"Kordes","year":"2007","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.trsl.2019.02.006_bib0034","doi-asserted-by":"crossref","first-page":"10512","DOI":"10.3748\/wjg.v22.i48.10512","article-title":"Liver fibrosis and hepatic stellate cells: etiology, pathological hallmarks and therapeutic targets","volume":"22","author":"Zhang","year":"2016","journal-title":"World J Gastroenterol"},{"issue":"7","key":"10.1016\/j.trsl.2019.02.006_bib0035","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1152\/physiolgenomics.00158.2013","article-title":"The wound healing, chronic fibrosis, and cancer progression triad","volume":"46","author":"Rybinski","year":"2014","journal-title":"Physiol Genomics"},{"key":"10.1016\/j.trsl.2019.02.006_bib0036","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1158\/2326-6066.CIR-14-0209","article-title":"Tumors: wounds that do not heal-redux","volume":"3","author":"Dvorak","year":"2015","journal-title":"Cancer Immunol Res"},{"key":"10.1016\/j.trsl.2019.02.006_bib0037","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1038\/nrm2455","article-title":"Cancer as an overhealing wound: an old hypothesis revisited","volume":"9","author":"Sch\u00e4fer","year":"2008","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1016\/j.trsl.2019.02.006_bib0038","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1038\/nature07039","article-title":"Wound repair and regeneration","volume":"453","author":"Gurtner","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.trsl.2019.02.006_bib0039","first-page":"5694","article-title":"Cancer-associated fibroblasts induce epithelial-mesenchymal transition through secreted cytokines in endometrial cancer cells","volume":"15","author":"Wang","year":"2018","journal-title":"Oncol Lett"},{"key":"10.1016\/j.trsl.2019.02.006_bib0040","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1002\/emmm.200900043","article-title":"Inflammation and EMT: an alliance towards organ fibrosis and cancer progression","volume":"1","author":"L\u00f3pez-Novoa","year":"2009","journal-title":"EMBO Mol Med"},{"key":"10.1016\/j.trsl.2019.02.006_bib0041","doi-asserted-by":"crossref","first-page":"12072","DOI":"10.1073\/pnas.211053698","article-title":"Senescent fibroblasts promote epithelial cell growth and tumorigenesis: a link between cancer and aging","volume":"98","author":"Krtolica","year":"2001","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.trsl.2019.02.006_bib0042","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1148\/radiol.10092129","article-title":"CT findings of chemotherapy-induced toxicity: what radiologists need to know about the clinical and radiologic manifestations of chemotherapy toxicity","volume":"258","author":"Torrisi","year":"2011","journal-title":"Radiology"},{"key":"10.1016\/j.trsl.2019.02.006_bib0043","doi-asserted-by":"crossref","first-page":"51","DOI":"10.3389\/fphar.2014.00051","article-title":"Mechanisms of cellular fibrosis associated with cancer regimen-related toxicities","volume":"5","author":"Mancini","year":"2014","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.trsl.2019.02.006_bib0044","doi-asserted-by":"crossref","first-page":"2851","DOI":"10.1084\/jem.20131195","article-title":"Chemotherapy activates cancer-associated fibroblasts to maintain colorectal cancer-initiating cells by IL-17A","volume":"210","author":"Lotti","year":"2013","journal-title":"J Exp Med"},{"key":"10.1016\/j.trsl.2019.02.006_bib0045","doi-asserted-by":"crossref","first-page":"91","DOI":"10.2174\/1874375700903020091","article-title":"Histopathology of colorectal cancer after neoadjuvant chemoradiation therapy","volume":"3","author":"O'Neil","year":"2009","journal-title":"Open Pathol J"},{"key":"10.1016\/j.trsl.2019.02.006_bib0046","article-title":"Postchemotherapy histopathological evaluation of ovarian carcinoma: a 40-case study","volume":"2015","author":"Tiwana","year":"2015","journal-title":"Chemother Res Pract"},{"key":"10.1016\/j.trsl.2019.02.006_bib0047","doi-asserted-by":"crossref","first-page":"111","DOI":"10.4103\/2229-516X.106353","article-title":"Histopathologic changes following neoadjuvant chemotherapy in various malignancies","volume":"2","author":"Sethi","year":"2012","journal-title":"Int J Appl Basic Med Res"},{"key":"10.1016\/j.trsl.2019.02.006_bib0048","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/j.radonc.2015.05.007","article-title":"Impact of neoadjuvant therapy on cancer-associated fibroblasts in rectal cancer","volume":"116","author":"Verset","year":"2015","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.trsl.2019.02.006_bib0049","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1002\/path.2277","article-title":"Cellular and molecular mechanisms of fibrosis","volume":"214","author":"Wynn","year":"2008","journal-title":"J Pathol"},{"key":"10.1016\/j.trsl.2019.02.006_bib0050","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1038\/nrc3958","article-title":"The tumour microenvironment after radiotherapy: mechanisms of resistance and recurrence","volume":"15","author":"Barker","year":"2015","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.trsl.2019.02.006_bib0051","doi-asserted-by":"crossref","first-page":"6734","DOI":"10.1158\/0008-5472.CAN-05-0703","article-title":"Cellular mechanisms for low-dose ionizing radiation-induced perturbation of the breast tissue microenvironment","volume":"65","author":"Tsai","year":"2005","journal-title":"Cancer Res"},{"key":"10.1016\/j.trsl.2019.02.006_bib0052","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.neo.2017.02.010","article-title":"Mesenchymal stem cells induce epithelial to mesenchymal transition in colon cancer cells through direct cell-to-cell contact","volume":"19","author":"Takigawa","year":"2017","journal-title":"Neoplasia"},{"key":"10.1016\/j.trsl.2019.02.006_bib0053","doi-asserted-by":"crossref","first-page":"2916","DOI":"10.7150\/jca.24415","article-title":"Stromal mesenchymal stem cells facilitate pancreatic cancer progression by regulating specific secretory molecules through mutual cellular interaction","volume":"9","author":"Saito","year":"2018","journal-title":"J Cancer"},{"key":"10.1016\/j.trsl.2019.02.006_bib0054","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1093\/carcin\/bgx045","article-title":"Microvesicles derived from normal and multiple myeloma bone marrow mesenchymal stem cells differentially modulate myeloma cells\u2019 phenotype and translation initiation","volume":"38","author":"Dabbah","year":"2017","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.trsl.2019.02.006_bib0055","article-title":"Ovarian carcinoma-associated mesenchymal stem cells arise from tissue-specific normal stroma","author":"Coffman","year":"2018","journal-title":"Stem Cells"},{"key":"10.1016\/j.trsl.2019.02.006_bib0056","article-title":"Leukemia inhibitory factor functions in parallel with interleukin-6 to promote ovarian cancer growth","author":"McLean","year":"2018","journal-title":"Oncogene"},{"key":"10.1016\/j.trsl.2019.02.006_bib0057","doi-asserted-by":"crossref","first-page":"13162","DOI":"10.1038\/s41598-017-13460-7","article-title":"Mesenchymal stem cells from tumor microenvironment favour breast cancer stem cell proliferation, cancerogenic and metastatic potential, via ionotropic purinergic signalling","volume":"7","author":"Maffey","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.trsl.2019.02.006_bib0058","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1158\/0008-5472.CAN-17-1547","article-title":"Therapy-educated mesenchymal stem cells enrich for tumor-initiating cells","volume":"78","author":"Timaner","year":"2018","journal-title":"Cancer Res"},{"key":"10.1016\/j.trsl.2019.02.006_bib0059","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1038\/nature06188","article-title":"Mesenchymal stem cells within tumour stroma promote breast cancer metastasis","volume":"449","author":"Karnoub","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.trsl.2019.02.006_bib0060","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.leukres.2017.07.002","article-title":"Mesenchymal stem cells derived from multiple myeloma patients protect against chemotherapy through autophagy-dependent activation of NF-\u03baB signaling","volume":"60","author":"Yang","year":"2017","journal-title":"Leuk Res"},{"key":"10.1016\/j.trsl.2019.02.006_bib0061","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s12964-018-0215-4","article-title":"Enhanced metastatic capacity of breast cancer cells after interaction and hybrid formation with mesenchymal stroma\/stem cells (MSC)","volume":"16","author":"Melzer","year":"2018","journal-title":"Cell Commun Signal"},{"key":"10.1016\/j.trsl.2019.02.006_bib0062","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/1859567","article-title":"Immunotolerant properties of mesenchymal stem cells: updated review","volume":"2016","author":"Faiella","year":"2016","journal-title":"Stem Cells Int"},{"key":"10.1016\/j.trsl.2019.02.006_bib0063","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1002\/stem.2509","article-title":"Mesenchymal stromal cell secretion of programmed death-1 ligands regulates T cell mediated immunosuppression","volume":"35","author":"Davies","year":"2017","journal-title":"Stem Cells"},{"key":"10.1016\/j.trsl.2019.02.006_bib0064","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1186\/s12967-016-1057-8","article-title":"Mesenchymal stromal cells derived from cervical cancer produce high amounts of adenosine to suppress cytotoxic T lymphocyte functions","volume":"14","author":"de Lourdes Mora-Garc\u00eda","year":"2016","journal-title":"J Transl Med"},{"key":"10.1016\/j.trsl.2019.02.006_bib0065","doi-asserted-by":"crossref","first-page":"2343","DOI":"10.1111\/j.1582-4934.2010.01215.x","article-title":"Immunosuppressive effect of bone marrow-derived mesenchymal stem cells in inflammatory microenvironment favours the growth of B16 melanoma cells","volume":"15","author":"Han","year":"2011","journal-title":"J Cell Mol Med"},{"key":"10.1016\/j.trsl.2019.02.006_bib0066","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.stem.2007.11.014","article-title":"Mesenchymal stem cell-mediated immunosuppression occurs via concerted action of chemokines and nitric oxide","volume":"2","author":"Ren","year":"2008","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.trsl.2019.02.006_bib0067","doi-asserted-by":"crossref","first-page":"5885","DOI":"10.4049\/jimmunol.0903143","article-title":"Mesenchymal stem cells protect breast cancer cells through regulatory T cells: role of mesenchymal stem cell-derived TGF-beta","volume":"184","author":"Patel","year":"2010","journal-title":"J Immunol"},{"key":"10.1016\/j.trsl.2019.02.006_bib0068","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1016\/j.stem.2012.08.013","article-title":"CCR2-dependent recruitment of macrophages by tumor-educated mesenchymal stromal cells promotes tumor development and is mimicked by TNF\u03b1","volume":"11","author":"Ren","year":"2012","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.trsl.2019.02.006_bib0069","doi-asserted-by":"crossref","first-page":"4283","DOI":"10.1158\/0008-5472.CAN-15-2812","article-title":"MFG-E8 drives melanoma growth by stimulating mesenchymal stromal cell-induced angiogenesis and M2 polarization of tumor-associated macrophages","volume":"76","author":"Yamada","year":"2016","journal-title":"Cancer Res"},{"key":"10.1016\/j.trsl.2019.02.006_bib0070","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.neo.2016.01.005","article-title":"Mesenchymal stem cells promote pancreatic tumor growth by inducing alternative polarization of macrophages","volume":"18","author":"Mathew","year":"2016","journal-title":"Neoplasia"},{"key":"10.1016\/j.trsl.2019.02.006_bib0071","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1042\/CS20110002","article-title":"Hepatic stellate cells stimulate HCC cell migration via laminin-5 production","volume":"121","author":"Santamato","year":"2011","journal-title":"Clin Sci"},{"key":"10.1016\/j.trsl.2019.02.006_bib0072","doi-asserted-by":"crossref","first-page":"2651","DOI":"10.1002\/ijc.25920","article-title":"Activated hepatic stellate cells promote hepatocellular carcinoma development in immunocompetent mice","volume":"129","author":"Zhao","year":"2011","journal-title":"Int J Cancer"},{"key":"10.1016\/j.trsl.2019.02.006_bib0073","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1053\/j.gastro.2013.07.025","article-title":"Activated pancreatic stellate cells sequester CD8+ T cells to reduce their infiltration of the juxtatumoral compartment of pancreatic ductal adenocarcinoma","volume":"145","author":"Ene-Obong","year":"2013","journal-title":"Gastroenterology"},{"key":"10.1016\/j.trsl.2019.02.006_bib0074","doi-asserted-by":"crossref","first-page":"3007","DOI":"10.1158\/0008-5472.CAN-12-4601","article-title":"Pancreatic cancer-associated stellate cells promote differentiation of myeloid-derived suppressor cells in a STAT3-dependent manner","volume":"73","author":"Mace","year":"2013","journal-title":"Cancer Res"},{"key":"10.1016\/j.trsl.2019.02.006_bib0075","doi-asserted-by":"crossref","first-page":"4861","DOI":"10.4049\/jimmunol.1202857","article-title":"Circulating fibrocytes prepare the lung for cancer metastasis by recruiting Ly-6C+ monocytes via CCL2","volume":"190","author":"van Deventer","year":"2013","journal-title":"J Immunol"},{"key":"10.1016\/j.trsl.2019.02.006_bib0076","doi-asserted-by":"crossref","first-page":"8792","DOI":"10.1038\/ncomms9792","article-title":"Fibrocyte-like cells mediate acquired resistance to anti-angiogenic therapy with bevacizumab","volume":"6","author":"Mitsuhashi","year":"2015","journal-title":"Nat Commun"},{"key":"10.1016\/j.trsl.2019.02.006_bib0077","doi-asserted-by":"crossref","DOI":"10.3390\/ijms19010098","article-title":"Fibrocytes: a novel stromal cells to regulate resistance to anti-angiogenic therapy and cancer progression","volume":"19","author":"Goto","year":"2017","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.trsl.2019.02.006_bib0078","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.canlet.2018.02.016","article-title":"Bone marrow-derived fibrocytes promote stem cell-like properties of lung cancer cells","volume":"421","author":"Saijo","year":"2018","journal-title":"Cancer Lett"},{"key":"10.1016\/j.trsl.2019.02.006_bib0079","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.ccr.2009.12.041","article-title":"Cancer-associated fibroblasts are activated in incipient neoplasia to orchestrate tumor-promoting inflammation in an NF-kappaB-dependent manner","volume":"17","author":"Erez","year":"2010","journal-title":"Cancer Cell"},{"key":"10.1016\/j.trsl.2019.02.006_bib0080","doi-asserted-by":"crossref","first-page":"e15313","DOI":"10.1371\/journal.pone.0015313","article-title":"Breast cancer cells induce cancer-associated fibroblasts to secrete hepatocyte growth factor to enhance breast tumorigenesis","volume":"6","author":"Tyan","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.trsl.2019.02.006_bib0081","doi-asserted-by":"crossref","DOI":"10.1177\/1010428317712592","article-title":"Cancer-associated fibroblasts secrete FGF-1 to promote ovarian proliferation, migration, and invasion through the activation of FGF-1\/FGFR4 signaling","volume":"39","author":"Sun","year":"2017","journal-title":"Tumour Biol"},{"key":"10.1016\/j.trsl.2019.02.006_bib0082","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1124\/mol.112.084079","article-title":"Inhibition of platelet-derived growth factor receptor \u03b1 by MEDI-575 reduces tumor growth and stromal fibroblast content in a model of non-small cell lung cancer","volume":"83","author":"Laing","year":"2013","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.trsl.2019.02.006_bib0083","doi-asserted-by":"crossref","first-page":"7194","DOI":"10.1038\/sj.onc.1210535","article-title":"The VEGF angiogenic switch of fibroblasts is regulated by MMP-7 from cancer cells","volume":"26","author":"Ito","year":"2007","journal-title":"Oncogene"},{"key":"10.1016\/j.trsl.2019.02.006_bib0084","doi-asserted-by":"crossref","first-page":"11924","DOI":"10.1038\/srep11924","article-title":"TGF\u03b21 secreted by cancer-associated fibroblasts induces epithelial-mesenchymal transition of bladder cancer cells through lncRNA-ZEB2NAT","volume":"5","author":"Zhuang","year":"2015","journal-title":"Sci Rep"},{"key":"10.1016\/j.trsl.2019.02.006_bib0085","doi-asserted-by":"crossref","first-page":"16002","DOI":"10.1073\/pnas.1109493108","article-title":"VEGF-A and tenascin-C produced by S100A4+ stromal cells are important for metastatic colonization","volume":"108","author":"O'Connell","year":"2011","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.trsl.2019.02.006_bib0086","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1042\/BST20160387","article-title":"Cancer-associated fibroblasts modulate growth factor signaling and extracellular matrix remodeling to regulate tumor metastasis","volume":"45","author":"Erdogan","year":"2017","journal-title":"Biochem Soc Trans"},{"key":"10.1016\/j.trsl.2019.02.006_bib0087","doi-asserted-by":"crossref","first-page":"E1413","DOI":"10.1073\/pnas.1621161114","article-title":"RhoA knockout fibroblasts lose tumor-inhibitory capacity in vitro and promote tumor growth in vivo","volume":"114","author":"Alkasalias","year":"2017","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.trsl.2019.02.006_bib0088","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1165\/rcmb.2012-0050OC","article-title":"Matrix stiffness-induced myofibroblast differentiation is mediated by intrinsic mechanotransduction","volume":"47","author":"Huang","year":"2012","journal-title":"Am J Respir Cell Mol Biol"},{"key":"10.1016\/j.trsl.2019.02.006_bib0089","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.92232","article-title":"Fibroblast activation protein augments progression and metastasis of pancreatic ductal adenocarcinoma","volume":"2","author":"Lo","year":"2017","journal-title":"JCI Insight"},{"key":"10.1016\/j.trsl.2019.02.006_bib0090","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/j.ccr.2012.08.013","article-title":"Dependency of colorectal cancer on a TGF-\u03b2-driven program in stromal cells for metastasis initiation","volume":"22","author":"Calon","year":"2012","journal-title":"Cancer Cell"},{"key":"10.1016\/j.trsl.2019.02.006_bib0091","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1007\/s00441-016-2471-1","article-title":"The roles of tumor- and metastasis-promoting carcinoma-associated fibroblasts in human carcinomas","volume":"365","author":"Mezawa","year":"2016","journal-title":"Cell Tissue Res"},{"key":"10.1016\/j.trsl.2019.02.006_bib0092","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.cell.2011.05.040","article-title":"Biomechanical remodeling of the microenvironment by stromal caveolin-1 favors tumor invasion and metastasis","volume":"146","author":"Goetz","year":"2011","journal-title":"Cell"},{"key":"10.1016\/j.trsl.2019.02.006_bib0093","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1007\/s13277-015-3942-9","article-title":"Cancer-associated fibroblasts promote angiogenesis in gastric cancer through galectin-1 expression","volume":"37","author":"Tang","year":"2016","journal-title":"Tumour Biol"},{"key":"10.1016\/j.trsl.2019.02.006_bib0094","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1002\/(SICI)1097-0215(19990730)82:3<449::AID-IJC20>3.0.CO;2-H","article-title":"Role of fibroblasts in HGF\/SF-induced cohort migration of human colorectal carcinoma cells: fibroblasts stimulate migration associated with increased fibronectin production via upregulated TGF-beta1","volume":"82","author":"Shimao","year":"1999","journal-title":"Int J Cancer"},{"key":"10.1016\/j.trsl.2019.02.006_bib0095","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.cell.2005.02.034","article-title":"Stromal fibroblasts present in invasive human breast carcinomas promote tumor growth and angiogenesis through elevated SDF-1\/CXCL12 secretion","volume":"121","author":"Orimo","year":"2005","journal-title":"Cell"},{"key":"10.1016\/j.trsl.2019.02.006_bib0096","doi-asserted-by":"crossref","first-page":"3783","DOI":"10.4161\/15384101.2014.988106","article-title":"CAF reprogramming inhibits ovarian cancer progression","volume":"13","author":"Yeung","year":"2014","journal-title":"Cell Cycle"},{"key":"10.1016\/j.trsl.2019.02.006_bib0097","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1002\/1878-0261.12327","article-title":"Loss of androgen receptor signaling in prostate cancer-associated fibroblasts (CAFs) promotes CCL2- and CXCL8-mediated cancer cell migration","volume":"12","author":"Cioni","year":"2018","journal-title":"Mol Oncol"},{"key":"10.1016\/j.trsl.2019.02.006_bib0098","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1038\/ni1197","article-title":"Transforming growth factor-beta controls T helper type 1 cell development through regulation of natural killer cell interferon-gamma","volume":"6","author":"Laouar","year":"2005","journal-title":"Nat Immunol"},{"key":"10.1016\/j.trsl.2019.02.006_bib0099","doi-asserted-by":"crossref","first-page":"20847","DOI":"10.1073\/pnas.0906481106","article-title":"Melanoma-associated fibroblasts modulate NK cell phenotype and antitumor cytotoxicity","volume":"106","author":"Balsamo","year":"2009","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.trsl.2019.02.006_bib0100","doi-asserted-by":"crossref","first-page":"2423","DOI":"10.1038\/onc.2013.191","article-title":"Cancer-associated fibroblasts and M2-polarized macrophages synergize during prostate carcinoma progression","volume":"33","author":"Comito","year":"2014","journal-title":"Oncogene"},{"key":"10.1016\/j.trsl.2019.02.006_bib0101","doi-asserted-by":"crossref","first-page":"63","DOI":"10.3389\/fonc.2015.00063","article-title":"Cancer-associated fibroblasts connect metastasis-promoting communication in colorectal cancer","volume":"5","author":"Tommelein","year":"2015","journal-title":"Front Oncol"},{"key":"10.1016\/j.trsl.2019.02.006_bib0102","doi-asserted-by":"crossref","first-page":"4124","DOI":"10.1158\/0008-5472.CAN-15-2973","article-title":"FAP promotes immunosuppression by cancer-associated fibroblasts in the tumor microenvironment via STAT3-CCL2 signaling","volume":"76","author":"Yang","year":"2016","journal-title":"Cancer Res"},{"key":"10.1016\/j.trsl.2019.02.006_bib0103","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1016\/j.ccell.2017.10.005","article-title":"Cancer-associated fibroblasts neutralize the anti-tumor effect of CSF1 receptor blockade by inducing PMN-MDSC infiltration of tumors","volume":"32","author":"Kumar","year":"2017","journal-title":"Cancer Cell"},{"key":"10.1016\/j.trsl.2019.02.006_bib0104","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.2217\/imt.12.112","article-title":"Cancer-associated fibroblasts as targets for immunotherapy","volume":"4","author":"Kakarla","year":"2012","journal-title":"Immunotherapy"},{"key":"10.1016\/j.trsl.2019.02.006_bib0105","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.jons.2017.04.001","article-title":"Indoleamine 2, 3-dioxygenase (IDO): only an enzyme or a checkpoint controller?","volume":"3","author":"Bilir","year":"2017","journal-title":"J Oncol Sci"},{"key":"10.1016\/j.trsl.2019.02.006_bib0106","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1158\/0008-5472.CAN-12-2325","article-title":"VEGFA-VEGFR pathway blockade inhibits tumor-induced regulatory T-cell proliferation in colorectal cancer","volume":"73","author":"Terme","year":"2013","journal-title":"Cancer Res"},{"key":"10.1016\/j.trsl.2019.02.006_bib0107","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1038\/nm1096-1096","article-title":"Production of vascular endothelial growth factor by human tumors inhibits the functional maturation of dendritic cells","volume":"2","author":"Gabrilovich","year":"1996","journal-title":"Nat Med"},{"key":"10.1016\/j.trsl.2019.02.006_bib0108","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1084\/jem.20140559","article-title":"VEGF-A modulates expression of inhibitory checkpoints on CD8+ T cells in tumors","volume":"212","author":"Voron","year":"2015","journal-title":"J Exp Med"},{"key":"10.1016\/j.trsl.2019.02.006_bib0109","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.4161\/cc.10.11.15659","article-title":"Evidence for a stromal-epithelial \u201clactate shuttle\u201d in human tumors: MCT4 is a marker of oxidative stress in cancer-associated fibroblasts","volume":"10","author":"Whitaker-Menezes","year":"2011","journal-title":"Cell Cycle"},{"key":"10.1016\/j.trsl.2019.02.006_bib0110","doi-asserted-by":"crossref","DOI":"10.1177\/1010428318756203","article-title":"Metabolic cooperation between cancer and non-cancerous stromal cells is pivotal in cancer progression","volume":"40","author":"Lopes-Coelho","year":"2018","journal-title":"Tumour Biol"},{"key":"10.1016\/j.trsl.2019.02.006_bib0111","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1016\/j.celrep.2015.02.006","article-title":"Metabolic reprogramming of cancer-associated fibroblasts by IDH3\u03b1 downregulation","volume":"10","author":"Zhang","year":"2015","journal-title":"Cell Rep"},{"key":"10.1016\/j.trsl.2019.02.006_bib0112","doi-asserted-by":"crossref","first-page":"5130","DOI":"10.1158\/0008-5472.CAN-12-1949","article-title":"Reciprocal metabolic reprogramming through lactate shuttle coordinately influences tumor-stroma interplay","volume":"72","author":"Fiaschi","year":"2012","journal-title":"Cancer Res"},{"key":"10.1016\/j.trsl.2019.02.006_bib0113","doi-asserted-by":"crossref","first-page":"2723","DOI":"10.4161\/cc.25695","article-title":"Oncogenes induce the cancer-associated fibroblast phenotype: metabolic symbiosis and \u201cfibroblast addiction\u201d are new therapeutic targets for drug discovery","volume":"12","author":"Lisanti","year":"2013","journal-title":"Cell Cycle"},{"key":"10.1016\/j.trsl.2019.02.006_bib0114","doi-asserted-by":"crossref","first-page":"2580","DOI":"10.4161\/cc.25510","article-title":"Oncogenes and inflammation rewire host energy metabolism in the tumor microenvironment: RAS and NF\u03baB target stromal MCT4","volume":"12","author":"Martinez-Outschoorn","year":"2013","journal-title":"Cell Cycle"},{"key":"10.1016\/j.trsl.2019.02.006_bib0115","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/j.cmet.2016.10.011","article-title":"Targeting stromal glutamine synthetase in tumors disrupts tumor microenvironment-regulated cancer cell growth","volume":"24","author":"Yang","year":"2016","journal-title":"Cell Metab"},{"key":"10.1016\/j.trsl.2019.02.006_bib0116","doi-asserted-by":"crossref","first-page":"3211","DOI":"10.1016\/j.bbamcr.2015.09.013","article-title":"Cancer associated fibroblasts transfer lipids and proteins to cancer cells through cargo vesicles supporting tumor growth","volume":"1853","author":"Santi","year":"2015","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.trsl.2019.02.006_bib0117","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/j.ccr.2012.01.007","article-title":"Enzymatic targeting of the stroma ablates physical barriers to treatment of pancreatic ductal adenocarcinoma","volume":"21","author":"Provenzano","year":"2012","journal-title":"Cancer Cell"},{"key":"10.1016\/j.trsl.2019.02.006_bib0118","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1136\/gutjnl-2012-302529","article-title":"Hyaluronan impairs vascular function and drug delivery in a mouse model of pancreatic cancer","volume":"62","author":"Jacobetz","year":"2013","journal-title":"Gut"},{"key":"10.1016\/j.trsl.2019.02.006_bib0119","doi-asserted-by":"crossref","first-page":"3453","DOI":"10.1158\/0008-5472.CAN-10-1633","article-title":"Pancreatic stellate cells radioprotect pancreatic cancer cells through \u03b21-integrin signaling","volume":"71","author":"Mantoni","year":"2011","journal-title":"Cancer Res"},{"key":"10.1016\/j.trsl.2019.02.006_bib0120","doi-asserted-by":"crossref","first-page":"6943","DOI":"10.1158\/1078-0432.CCR-13-1637","article-title":"Tumor stromal architecture can define the intrinsic tumor response to VEGF-targeted therapy","volume":"19","author":"Smith","year":"2013","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.trsl.2019.02.006_bib0121","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1172\/JCI45817","article-title":"Matrix architecture defines the preferential localization and migration of T cells into the stroma of human lung tumors","volume":"122","author":"Salmon","year":"2012","journal-title":"J Clin Invest"},{"key":"10.1016\/j.trsl.2019.02.006_bib0122","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1126\/science.1198443","article-title":"CD40 agonists alter tumor stroma and show efficacy against pancreatic carcinoma in mice and humans","volume":"331","author":"Beatty","year":"2011","journal-title":"Science"},{"key":"10.1016\/j.trsl.2019.02.006_bib0123","doi-asserted-by":"crossref","first-page":"11208","DOI":"10.1073\/pnas.1610347113","article-title":"Oriented collagen fibers direct tumor cell intravasation","volume":"113","author":"Han","year":"2016","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.trsl.2019.02.006_bib0124","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1016\/j.cell.2009.10.027","article-title":"Matrix crosslinking forces tumor progression by enhancing integrin signaling","volume":"139","author":"Levental","year":"2009","journal-title":"Cell"},{"key":"10.1016\/j.trsl.2019.02.006_bib0125","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1111\/iep.12269","article-title":"Charting the unexplored extracellular matrix in cancer","volume":"99","author":"Filipe","year":"2018","journal-title":"Int J Exp Pathol"},{"key":"10.1016\/j.trsl.2019.02.006_bib0126","doi-asserted-by":"crossref","first-page":"2871","DOI":"10.1007\/s13277-013-1511-7","article-title":"Collagen as a double-edged sword in tumor progression","volume":"35","author":"Fang","year":"2014","journal-title":"Tumour Biol"},{"key":"10.1016\/j.trsl.2019.02.006_bib0127","doi-asserted-by":"crossref","first-page":"11089","DOI":"10.1158\/0008-5472.CAN-06-2407","article-title":"Preparing the \u201csoil\u201d: the premetastatic niche","volume":"66","author":"Kaplan","year":"2006","journal-title":"Cancer Res"},{"key":"10.1016\/j.trsl.2019.02.006_bib0128","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1002\/hep.27378","article-title":"Tissue inhibitor of metalloproteinases (TIMP)-1 creates a premetastatic niche in the liver through SDF-1\/CXCR4-dependent neutrophil recruitment in mice","volume":"61","author":"Seubert","year":"2015","journal-title":"Hepatology"},{"key":"10.1016\/j.trsl.2019.02.006_bib0129","doi-asserted-by":"crossref","first-page":"12061","DOI":"10.18632\/oncotarget.3616","article-title":"TIMP-1 activated carcinoma-associated fibroblasts inhibit tumor apoptosis by activating SDF1\/CXCR4 signaling in hepatocellular carcinoma","volume":"6","author":"Song","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.trsl.2019.02.006_bib0130","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.ccr.2008.11.012","article-title":"Hypoxia-induced lysyl oxidase is a critical mediator of bone marrow cell recruitment to form the premetastatic niche","volume":"15","author":"Erler","year":"2009","journal-title":"Cancer Cell"},{"key":"10.1016\/j.trsl.2019.02.006_bib0131","doi-asserted-by":"crossref","first-page":"17188","DOI":"10.1073\/pnas.1419554111","article-title":"Inhibition of tumor cell proliferation and motility by fibroblasts is both contact and soluble factor dependent","volume":"111","author":"Alkasalias","year":"2014","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.trsl.2019.02.006_bib0132","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1089\/scd.2012.0304","article-title":"Microvesicles derived from human bone marrow mesenchymal stem cells inhibit tumor growth","volume":"22","author":"Bruno","year":"2013","journal-title":"Stem Cells Dev"},{"key":"10.1016\/j.trsl.2019.02.006_bib0133","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/j.ccr.2014.04.005","article-title":"Depletion of carcinoma-associated fibroblasts and fibrosis induces immunosuppression and accelerates pancreas cancer with reduced survival","volume":"25","author":"\u00d6zdemir","year":"2014","journal-title":"Cancer Cell"},{"key":"10.1016\/j.trsl.2019.02.006_bib0134","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/j.ccr.2014.04.021","article-title":"Stromal elements act to restrain, rather than support, pancreatic ductal adenocarcinoma","volume":"25","author":"Rhim","year":"2014","journal-title":"Cancer Cell"},{"key":"10.1016\/j.trsl.2019.02.006_bib0135","doi-asserted-by":"crossref","first-page":"E3091","DOI":"10.1073\/pnas.1411679111","article-title":"Stromal response to Hedgehog signaling restrains pancreatic cancer progression","volume":"111","author":"Lee","year":"2014","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.trsl.2019.02.006_bib0136","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.ccell.2014.09.001","article-title":"Hedgehog signaling restrains bladder cancer progression by eliciting stromal production of urothelial differentiation factors","volume":"26","author":"Shin","year":"2014","journal-title":"Cancer Cell"},{"key":"10.1016\/j.trsl.2019.02.006_bib0137","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/j.celrep.2014.09.010","article-title":"Dosage-dependent regulation of pancreatic cancer growth and angiogenesis by hedgehog signaling","volume":"9","author":"Mathew","year":"2014","journal-title":"Cell Rep"},{"key":"10.1016\/j.trsl.2019.02.006_bib0138","doi-asserted-by":"crossref","first-page":"5937","DOI":"10.1158\/1078-0432.CCR-14-1269","article-title":"Pilot clinical trial of hedgehog pathway inhibitor GDC-0449 (vismodegib) in combination with gemcitabine in patients with metastatic pancreatic adenocarcinoma","volume":"20","author":"Kim","year":"2014","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.trsl.2019.02.006_bib0139","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1158\/1535-7163.MCT-11-1058","article-title":"Smoothened antagonists reverse taxane resistance in ovarian cancer","volume":"11","author":"Steg","year":"2012","journal-title":"Mol Cancer Ther"},{"key":"10.1016\/j.trsl.2019.02.006_bib0140","first-page":"1643","article-title":"The Hedgehog inhibitor cyclopamine antagonizes chemoresistance of breast cancer cells","volume":"6","author":"Chai","year":"2013","journal-title":"Onco Targets Ther"},{"key":"10.1016\/j.trsl.2019.02.006_bib0141","doi-asserted-by":"crossref","first-page":"e28077","DOI":"10.1371\/journal.pone.0028077","article-title":"Inhibition of Hedgehog signaling antagonizes serous ovarian cancer growth in a primary xenograft model","volume":"6","author":"McCann","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.trsl.2019.02.006_bib0142","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1038\/nrm3598","article-title":"The mechanisms of Hedgehog signalling and its roles in development and disease","volume":"14","author":"Briscoe","year":"2013","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1016\/j.trsl.2019.02.006_bib0143","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1002\/wdev.70","article-title":"The sonic hedgehog gradient in the developing limb","volume":"2","author":"Tickle","year":"2013","journal-title":"Wiley Interdiscip Rev Dev Biol"},{"key":"10.1016\/j.trsl.2019.02.006_bib0144","doi-asserted-by":"crossref","first-page":"3772","DOI":"10.1158\/0008-5472.CAN-04-4510","article-title":"Suppression of tumor development and metastasis formation in mice lacking the S100A4(mts1) gene","volume":"65","author":"Grum-Schwensen","year":"2005","journal-title":"Cancer Res"},{"key":"10.1016\/j.trsl.2019.02.006_bib0145","doi-asserted-by":"crossref","first-page":"4584","DOI":"10.1158\/1078-0432.CCR-07-5211","article-title":"Effective immunoconjugate therapy in cancer models targeting a serine protease of tumor fibroblasts","volume":"14","author":"Ostermann","year":"2008","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.trsl.2019.02.006_bib0146","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1038\/mt.2013.110","article-title":"Antitumor effects of chimeric receptor engineered human T cells directed to tumor stroma","volume":"21","author":"Kakarla","year":"2013","journal-title":"Mol Ther"},{"key":"10.1016\/j.trsl.2019.02.006_bib0147","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1158\/2326-6066.CIR-13-0027","article-title":"Targeting fibroblast activation protein in tumor stroma with chimeric antigen receptor T cells can inhibit tumor growth and augment host immunity without severe toxicity","volume":"2","author":"Wang","year":"2014","journal-title":"Cancer Immunol Res"},{"key":"10.1016\/j.trsl.2019.02.006_bib0148","doi-asserted-by":"crossref","first-page":"2800","DOI":"10.1158\/0008-5472.CAN-14-3041","article-title":"Tumor-promoting desmoplasia is disrupted by depleting FAP-expressing stromal cells","volume":"75","author":"Lo","year":"2015","journal-title":"Cancer Res"},{"key":"10.1016\/j.trsl.2019.02.006_bib0149","doi-asserted-by":"crossref","first-page":"3613","DOI":"10.1172\/JCI38988","article-title":"Targeting fibroblast activation protein inhibits tumor stromagenesis and growth in mice","volume":"119","author":"Santos","year":"2009","journal-title":"J Clin Invest"},{"key":"10.1016\/j.trsl.2019.02.006_bib0150","doi-asserted-by":"crossref","first-page":"20212","DOI":"10.1073\/pnas.1320318110","article-title":"Targeting CXCL12 from FAP-expressing carcinoma-associated fibroblasts synergizes with anti-PD-L1 immunotherapy in pancreatic cancer","volume":"110","author":"Feig","year":"2013","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.trsl.2019.02.006_bib0151","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1158\/1078-0432.CCR-12-1800","article-title":"A randomized phase II trial of vismodegib versus placebo with FOLFOX or FOLFIRI and bevacizumab in patients with previously untreated metastatic colorectal cancer","volume":"19","author":"Berlin","year":"2013","journal-title":"Clin Cancer Res"},{"issue":"3_suppl","key":"10.1016\/j.trsl.2019.02.006_bib0152","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1200\/jco.2014.32.3_suppl.257","article-title":"A phase II study of vismodegib, a hedgehog (Hh) pathway inhibitor, combined with gemcitabine and nab-paclitaxel (nab-P) in patients (pts) with untreated metastatic pancreatic ductal adenocarcinoma (PDA)","volume":"32","author":"De Jesus-Acosta","year":"2014","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.trsl.2019.02.006_bib0153","unstructured":"Infinity Reports Update from Phase 2 Study of Saridegib Plus Gemcitabine in Patients with Metastatic Pancreatic Cancer | Business Wire. Available at: https:\/\/www.businesswire.com\/news\/home\/20120127005146\/en\/Infinity-Reports-Update-Phase-2-Study-Saridegib#.UxAvFfRdVxV. Accessed December 8, 2018."},{"key":"10.1016\/j.trsl.2019.02.006_bib0154","doi-asserted-by":"crossref","first-page":"4284","DOI":"10.1200\/JCO.2015.62.8719","article-title":"Randomized phase IB\/II study of gemcitabine plus placebo or vismodegib, a hedgehog pathway inhibitor, in patients with metastatic pancreatic cancer","volume":"33","author":"Catenacci","year":"2015","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.trsl.2019.02.006_bib0155","first-page":"5002","article-title":"Carcinoma-associated fibroblasts direct tumor progression of initiated human prostatic epithelium","volume":"59","author":"Olumi","year":"1999","journal-title":"Cancer Res"},{"key":"10.1016\/j.trsl.2019.02.006_bib0156","doi-asserted-by":"crossref","first-page":"513","DOI":"10.3109\/07357907.2012.692171","article-title":"Human bone marrow-derived mesenchymal stem cells produced TGFbeta contributes to progression and metastasis of prostate cancer","volume":"30","author":"Ye","year":"2012","journal-title":"Cancer Invest"},{"key":"10.1016\/j.trsl.2019.02.006_bib0157","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1016\/S0002-9440(10)63510-9","article-title":"Transgenic mice expressing a dominant-negative mutant type II transforming growth factor-beta receptor exhibit impaired mammary development and enhanced mammary tumor formation","volume":"163","author":"Gorska","year":"2003","journal-title":"Am J Pathol"},{"key":"10.1016\/j.trsl.2019.02.006_bib0158","doi-asserted-by":"crossref","first-page":"239","DOI":"10.4067\/S0716-97602002000200016","article-title":"Regulation of Rho family GTPases by cell-cell and cell-matrix adhesion","volume":"35","author":"Arthur","year":"2002","journal-title":"Biol Res"},{"key":"10.1016\/j.trsl.2019.02.006_bib0159","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1242\/jcs.001586","article-title":"Force activates smooth muscle alpha-actin promoter activity through the Rho signaling pathway","volume":"120","author":"Zhao","year":"2007","journal-title":"J Cell Sci"},{"key":"10.1016\/j.trsl.2019.02.006_bib0160","doi-asserted-by":"crossref","first-page":"e98116","DOI":"10.1371\/journal.pone.0098116","article-title":"Influence of ARHGEF3 and RHOA knockdown on ACTA2 and other genes in osteoblasts and osteoclasts","volume":"9","author":"Mullin","year":"2014","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.trsl.2019.02.006_bib0161","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1172\/JCI66700","article-title":"Inhibition of mechanosensitive signaling in myofibroblasts ameliorates experimental pulmonary fibrosis","volume":"123","author":"Zhou","year":"2013","journal-title":"J Clin Invest"},{"key":"10.1016\/j.trsl.2019.02.006_bib0162","article-title":"Fibroblast activation protein overexpression and clinical implications in solid tumors: a meta-analysis","volume":"10","author":"Liu","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.trsl.2019.02.006_bib0163","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1186\/s12876-015-0340-0","article-title":"Fibroblast activation protein-\u03b1-expressing fibroblasts promote the progression of pancreatic ductal adenocarcinoma","volume":"15","author":"Kawase","year":"2015","journal-title":"BMC Gastroenterol"},{"key":"10.1016\/j.trsl.2019.02.006_bib0164","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.2174\/156652412803833607","article-title":"Fibroblast activation protein in remodeling tissues","volume":"12","author":"Jacob","year":"2012","journal-title":"Curr Mol Med"},{"key":"10.1016\/j.trsl.2019.02.006_bib0165","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1126\/science.1195300","article-title":"Suppression of antitumor immunity by stromal cells expressing fibroblast activation protein-alpha","volume":"330","author":"Kraman","year":"2010","journal-title":"Science"},{"key":"10.1016\/j.trsl.2019.02.006_bib0166","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1172\/JCI26532","article-title":"Targeting tumor-associated fibroblasts improves cancer chemotherapy by increasing intratumoral drug uptake","volume":"116","author":"Loeffler","year":"2006","journal-title":"J Clin Invest"},{"key":"10.1016\/j.trsl.2019.02.006_bib0167","doi-asserted-by":"crossref","first-page":"11156","DOI":"10.1158\/0008-5472.CAN-05-2805","article-title":"Tumor immunotherapy targeting fibroblast activation protein, a product expressed in tumor-associated fibroblasts","volume":"65","author":"Lee","year":"2005","journal-title":"Cancer Res"}],"container-title":["Translational Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1931524419300386?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1931524419300386?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T12:39:37Z","timestamp":1761827977000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1931524419300386"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7]]},"references-count":167,"alternative-id":["S1931524419300386"],"URL":"https:\/\/doi.org\/10.1016\/j.trsl.2019.02.006","relation":{},"ISSN":["1931-5244"],"issn-type":[{"value":"1931-5244","type":"print"}],"subject":[],"published":{"date-parts":[[2019,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The double edge sword of fibrosis in cancer","name":"articletitle","label":"Article Title"},{"value":"Translational Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.trsl.2019.02.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}